Infusion of mesenchymal stem cells overexpressing GDNF ameliorates renal function in nephrotoxic serum nephritis - PubMed (original) (raw)
doi: 10.1002/cbf.1827. Epub 2011 Nov 22.
Affiliations
- PMID: 22105543
- DOI: 10.1002/cbf.1827
Infusion of mesenchymal stem cells overexpressing GDNF ameliorates renal function in nephrotoxic serum nephritis
Zheng-Yu Huang et al. Cell Biochem Funct. 2012 Mar.
Abstract
Nephrotoxic serum nephritis (NSN) is a well-established animal model of glomerulonephritis, a frequent clinical condition with a high mortality rate owing to the ineffectiveness of current therapies. Mesenchymal stem cells (MSCs) are adult stem cells with potential as novel therapies in regenerative medicine owing to the absence of allogenic rejection. Glial cell-derived neurotrophic factor (GDNF) acts as a morphogen in kidney development. The therapeutic effectiveness of bone marrow MSCs overexpressing GDNF (GDNF-MSCs) was evaluated in an NSN rat model. An adenoviral vector was used to transduce MSCs with GDNF and a green fluorescent protein reporter gene. Then, GDNF-MSCs were injected into NSN rats via the renal artery. The influence of GDNF on renal injury was assessed. The location of GDNF-MSCs in kidneys was detected using fluorescence microscopy, cells were counted, and kidney function was measured. Infusion of GNDF-MSCs enhanced the recovery of renal function in NSN rats. MSCs were detected in the kidney cortex after injection. Compared with control MSCs, GDNF-MSCs led to significantly better renal function and injury recovery in NSN rats. GDNF has a positive effect on MSC differentiation in renal tissue. Owing to their highly renoprotective capacity, GDNF-MSCs represent a possible novel cell-based paradigm for treatment of glomerulonephritis.
Copyright © 2011 John Wiley & Sons, Ltd.
Similar articles
- Glial cell line-derived neurotrophic growth factor increases motility and survival of cultured mesenchymal stem cells and ameliorates acute kidney injury.
Shi H, Patschan D, Dietz GP, Bähr M, Plotkin M, Goligorsky MS. Shi H, et al. Am J Physiol Renal Physiol. 2008 Jan;294(1):F229-35. doi: 10.1152/ajprenal.00386.2007. Epub 2007 Nov 14. Am J Physiol Renal Physiol. 2008. PMID: 18003856 - Neurotrophic factor-expressing mesenchymal stem cells survive transplantation into the contused spinal cord without differentiating into neural cells.
Rooney GE, McMahon SS, Ritter T, Garcia Y, Moran C, Madigan NN, Flügel A, Dockery P, O'Brien T, Howard L, Windebank AJ, Barry FP. Rooney GE, et al. Tissue Eng Part A. 2009 Oct;15(10):3049-59. doi: 10.1089/ten.TEA.2009.0045. Tissue Eng Part A. 2009. PMID: 19335061 - GDNF-secreting mesenchymal stem cells provide localized neuroprotection in an inflammation-driven rat model of Parkinson's disease.
Hoban DB, Howard L, Dowd E. Hoban DB, et al. Neuroscience. 2015 Sep 10;303:402-11. doi: 10.1016/j.neuroscience.2015.07.014. Epub 2015 Jul 10. Neuroscience. 2015. PMID: 26166730 - Mesenchymal stem cells: therapeutic outlook for stroke.
Honmou O, Onodera R, Sasaki M, Waxman SG, Kocsis JD. Honmou O, et al. Trends Mol Med. 2012 May;18(5):292-7. doi: 10.1016/j.molmed.2012.02.003. Epub 2012 Mar 27. Trends Mol Med. 2012. PMID: 22459358 Review. - Mesenchymal stem cell interactions with growth factors on kidney repair.
Baer PC, Geiger H. Baer PC, et al. Curr Opin Nephrol Hypertens. 2010 Jan;19(1):1-6. doi: 10.1097/MNH.0b013e328333062c. Curr Opin Nephrol Hypertens. 2010. PMID: 19838114 Review.
Cited by
- Renal protective effects of helix B surface polypeptide in rats with puromycin aminonucleoside nephropathy.
Chen T, Shen XY, Liang HM, Shi H, Yuan L. Chen T, et al. Ren Fail. 2024 Dec;46(2):2394637. doi: 10.1080/0886022X.2024.2394637. Epub 2024 Aug 27. Ren Fail. 2024. PMID: 39189638 Free PMC article. - Microvascular Inflammation of the Renal Allograft: A Reappraisal of the Underlying Mechanisms.
Lebraud E, Eloudzeri M, Rabant M, Lamarthée B, Anglicheau D. Lebraud E, et al. Front Immunol. 2022 Mar 22;13:864730. doi: 10.3389/fimmu.2022.864730. eCollection 2022. Front Immunol. 2022. PMID: 35392097 Free PMC article. Review. - Genetic Engineering as a Strategy to Improve the Therapeutic Efficacy of Mesenchymal Stem/Stromal Cells in Regenerative Medicine.
Damasceno PKF, de Santana TA, Santos GC, Orge ID, Silva DN, Albuquerque JF, Golinelli G, Grisendi G, Pinelli M, Ribeiro Dos Santos R, Dominici M, Soares MBP. Damasceno PKF, et al. Front Cell Dev Biol. 2020 Aug 21;8:737. doi: 10.3389/fcell.2020.00737. eCollection 2020. Front Cell Dev Biol. 2020. PMID: 32974331 Free PMC article. Review. - Expression Analysis of GDNF/RET Signaling Pathway in Human AD-MSCs Grown in HEK 293 Conditioned Medium (HEK293-CM).
Esmaeilizadeh Z, Mohammadi B, Rajabibazl M, Ghaderian SMH, Omrani MD, Fazeli Z. Esmaeilizadeh Z, et al. Cell Biochem Biophys. 2020 Dec;78(4):531-539. doi: 10.1007/s12013-020-00936-z. Epub 2020 Aug 14. Cell Biochem Biophys. 2020. PMID: 32803668 - What is new in the management of rapidly progressive glomerulonephritis?
Greenhall GH, Salama AD. Greenhall GH, et al. Clin Kidney J. 2015 Apr;8(2):143-50. doi: 10.1093/ckj/sfv008. Epub 2015 Feb 19. Clin Kidney J. 2015. PMID: 25815169 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources